{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:38:55Z","timestamp":1789763935182,"version":"4.0.1"},"reference-count":46,"publisher":"Bentham Science Publishers Ltd.","issue":"10","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPD"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Neuromyelitis optica (NMO) is a severe neurological demyelinating autoimmune disease\naffecting the optic nerves and spinal cord. The binding of neuromyelitis optica immunoglobulin G (NMO-\nIgG) and aquaporin-4 (AQP4) on the surface of astrocytes in the serum and cerebrospinal fluid is the main\npathogenesis of NMO. Currently, therapeutic strategies for NMO include a reduction of the secondary inflammation\nresponse and the number of NMO-IgG, which can only alleviate clinical symptoms rather than fundamentally\npreventing a series of pathological processes caused by NMO-IgG binding to AQP4.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The purpose of this study was to investigate the blocking effect of melanthioidine on the binding of\nNMO-IgG to AQP4 and its potential cytotoxicity.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The current study developed a cell-based high-throughput screening approach to identify a molecular\nblocker of NMO-IgG binding to AQP4 using the Chinese hamster lung fibroblast (V79) cells expressing M23-\nAQP4. By screening ~400 small molecules, we identified melanthioidine with blocking effects without affecting\nAQP4 expression or its water permeability.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Melanthioidine effectively blocked the binding of NMO-IgG to AQP4 in immunofluorescence assays\nand reduced complement-dependent cytotoxicity against both NMO-IgG\/complement-treated Fischer rat thyroid-\nAQP4 cells and primary astrocytes. The docking computations identified the putative sites of blocker binding\nat the extracellular surface of AQP4.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>This study serves as proof of a potential NMO therapy by using a small-molecule blocker to target\nNMO pathogenesis.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1381612829666230330090953","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T03:58:20Z","timestamp":1680235100000},"page":"793-802","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Inhibition of Neuromyelitis Optica Immunoglobulin G Binding to Aquaporin-4\nby the Small Molecule Blocker Melanthioidine"],"prefix":"10.2174","volume":"29","author":[{"given":"Huijing","family":"Xu","sequence":"first","affiliation":[{"name":"College of Laboratory Medicine, Jilin Medical University, Jilin, 132013, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushuang","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The China-Japan\nUnion Hospital, Jilin University, Changchun, 130033, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Jiao","sequence":"additional","affiliation":[{"name":"College of Laboratory Medicine, Jilin Medical University, Jilin, 132013, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Guo","sequence":"additional","affiliation":[{"name":"College of Laboratory Medicine, Jilin Medical University, Jilin, 132013, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The China-Japan\nUnion Hospital, Jilin University, Changchun, 130033, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juechen","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, University of Cincinnati College\nof Medical, Cincinnati, OH, 58103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibin","family":"Tong","sequence":"additional","affiliation":[{"name":"College of Life and Environmental Science, Wenzhou University, Wenzhou, 325035,\nChina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyan","family":"Sun","sequence":"additional","affiliation":[{"name":"College of Laboratory Medicine, Jilin Medical University, Jilin, 132013, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The China-Japan\nUnion Hospital, Jilin University, Changchun, 130033, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1177\/1352458515572406","volume":"21","author":"Pandit L.","year":"2015","unstructured":"Pandit L.; Asgari N.; Apiwattanakul M.; Palace J.; Paul F.; Leite M.I.; Kleiter I.; Chitnis T.; Demographic and clinical features of neuromyelitis optica: A review. Mult Scler GJCF International clinical consortium and biorepository for neuromyelitis optica2015,21(7),845-853","journal-title":"Mult Scler"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/ana.24617","volume":"79","author":"Flanagan E.P.","year":"2016","unstructured":"Flanagan E.P.; Cabre P.; Weinshenker B.G.; Sauver J.S.; Jacobson D.J.; Majed M.; Lennon V.A.; Lucchinetti C.F.; McKeon A.; Matiello M.; Kale N.; Wingerchuk D.M.; Mandrekar J.; Sagen J.A.; Fryer J.P.; Robinson A.B.; Pittock S.J.; Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum. Ann Neurol 2016,79(5),775-783","journal-title":"Ann Neurol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1055\/s-0035-1554101","volume":"46","author":"Gross C.","year":"2015","unstructured":"Gross C.; Fiedler B.; Meuth S.; Kurlemann G.; Elpers C.; A case report on juvenile neuromyelitis optica: Early onset, long remission period, and atypical treatment response. Neuropediatrics 2015,46(4),292-295","journal-title":"Neuropediatrics"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"331","DOI":"10.4103\/0976-3147.158755","volume":"6","author":"Jagtap S.A.","year":"2015","unstructured":"Jagtap S.A.; Mandliya A.; Sarada C.; Nair M.D.; Neuromyelitis optica and neuromyelitis optica spectrum disorder: Natural history and long-term outcome, an Indian experience. J Neurosci Rural Pract 2015,6(3),331-335","journal-title":"J Neurosci Rural Pract"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1007\/s00415-011-6355-8","volume":"259","author":"Jarius S.","year":"2012","unstructured":"Jarius S.; Wildemann B.; The case of the Marquis de Causan (1804): An early account of visual loss associated with spinal cord inflammation. J Neurol 2012,259(7),1354-1357","journal-title":"J Neurol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1186\/1742-2094-10-8","volume":"10","author":"Jarius S.","year":"2013","unstructured":"Jarius S.; Wildemann B.; The history of neuromyelitis optica. J Neuroinflammation 2013,10(1),797","journal-title":"J Neuroinflammation"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1038\/ncpneuro0501","volume":"3","author":"Jarius S.","year":"2007","unstructured":"Jarius S.; Paul F.; Franciotta D.; Aktas O.; Hohlfeld R.; Zipp F.; Vincent A.; Revised diagnostic criteria for neuromyelitis optica\u2014incorporation of NMO-IgG status. Nat Clin Pract Neurol 2007,3(5),E1-E1","journal-title":"Nat Clin Pract Neurol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","volume":"66","author":"Wingerchuk D.M.","year":"2006","unstructured":"Wingerchuk D.M.; Lennon V.A.; Pittock S.J.; Lucchinetti C.F.; Weinshenker B.G.; Revised diagnostic criteria for neuromyelitis optica. Neurology 2006,66(10),1485-1489","journal-title":"Neurology"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/bpa.12084","volume":"23","author":"Jarius S.","year":"2013","unstructured":"Jarius S.; Wildemann B.; Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: A critical review of the literature. Brain Pathol 2013,23(6),661-683","journal-title":"Brain Pathol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"Wingerchuk D.M.","year":"2015","unstructured":"Wingerchuk D.M.; Banwell B.; Bennett J.L.; Cabre P.; Carroll W.; Chitnis T.; de Seze J.; Fujihara K.; Greenberg B.; Jacob A.; Jarius S.; Lana-Peixoto M.; Levy M.; Simon J.H.; Tenembaum S.; Traboulsee A.L.; Waters P.; Wellik K.E.; Weinshenker B.G.; International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015,85(2),177-189","journal-title":"Neurology"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2147\/NDT.S185336","volume":"15","author":"Ai N.","year":"2019","unstructured":"Ai N.; Liu H.; Zhou H.; Lin D.; Wang J.; Yang M.; Song H.; Sun M.; Xu Q.; Wei S.; Cytokines and chemokines expression in serum of patients with neuromyelitis optica. Neuropsychiatr Dis Treat 2019,15,303-310","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s40478-019-0766-7","volume":"7","author":"Duan T.","year":"2019","unstructured":"Duan T.; Smith A.J.; Verkman A.S.; Complement-independent bystander injury in AQP4-IgG seropositive neuromyelitis optica produced by antibody-dependent cellular cytotoxicity. Acta Neuropathol Commun 2019,7(1),112","journal-title":"Acta Neuropathol Commun"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3390\/ijms17030273","volume":"17","author":"Jasiak-Zatonska M.","year":"2016","unstructured":"Jasiak-Zatonska M.; Kalinowska-Lyszczarz A.; Michalak S.; Kozubski W.; The immunology of neuromyelitis optica\u2014current knowledge, clinical implications, controversies and future perspectives. Int J Mol Sci 2016,17(3),273","journal-title":"Int J Mol Sci"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1172\/JCI122942","volume":"129","author":"Soltys J.","year":"2019","unstructured":"Soltys J.; Liu Y.; Ritchie A.; Wemlinger S.; Schaller K.; Schumann H.; Owens G.P.; Bennett J.L.; Membrane assembly of aquaporin-4 autoantibodies regulates classical complement activation in neuromyelitis optica. J Clin Invest 2019,129(5),2000-2013","journal-title":"J Clin Invest"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1586\/14737175.2016.1150178","volume":"16","author":"Kitley J.","year":"2016","unstructured":"Kitley J.; Palace J.; Therapeutic options in neuromyelitis optica spectrum disorders. Expert Rev Neurother 2016,16(3),319-329","journal-title":"Expert Rev Neurother"},{"key":"ref=16","first-page":"573","volume":"71","author":"Kuroda H","year":"2019","unstructured":"Kuroda H; Fujihara K; Current status and prospects of complement-targeting therapy for neuromyelitis optica. Brain Nerve 2019,71(6),573-580","journal-title":"Brain Nerve"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s40478-015-0259-2","volume":"3","author":"Kurosawa K.","year":"2015","unstructured":"Kurosawa K.; Misu T.; Takai Y.; Sato D.K.; Takahashi T.; Abe Y.; Iwanari H.; Ogawa R.; Nakashima I.; Fujihara K.; Hamakubo T.; Yasui M.; Aoki M.; Severely exacerbated neuromyelitis optica rat model with extensive astrocytopathy by high affinity anti-aquaporin-4 monoclonal antibody. Acta Neuropathol Commun 2015,3(1),82","journal-title":"Acta Neuropathol Commun"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrneurol.2014.141","volume":"10","author":"Papadopoulos M.C.","year":"2014","unstructured":"Papadopoulos M.C.; Bennett J.L.; Verkman A.S.; Treatment of neuromyelitis optica: State-of-the-art and emerging therapies. Nat Rev Neurol 2014,10(9),493-506","journal-title":"Nat Rev Neurol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.msard.2017.09.015","volume":"18","author":"Sahraian M.A.","year":"2017","unstructured":"Sahraian M.A.; Moghadasi A.N.; Azimi A.R.; Asgari N.; H Akhoundi F.; Abolfazli R.; Alaie S.; Ashtari F.; Ayromlou H.; Baghbanian S.M.; Moghadam N.B.; Fatehi F.; Foroughipour M.; Langroodi H.G.; Majdinasab N.; Nickseresht A.; Nourian A.; Shaygannejad V.; Torabi H.R.; Diagnosis and management of Neuromyelitis Optica Spectrum Disorder (NMOSD) in Iran: A consensus guideline and recommendations. Mult Scler Relat Disord 2017,18,144-151","journal-title":"Mult Scler Relat Disord"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/ana.22657","volume":"71","author":"Tradtrantip L.","year":"2012","unstructured":"Tradtrantip L.; Zhang H.; Saadoun S.; Phuan P.W.; Lam C.; Papadopoulos M.C.; Bennett J.L.; Verkman A.S.; Anti-Aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica. Ann Neurol 2012,71(3),314-322","journal-title":"Ann Neurol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1080\/14728222.2017.1398236","volume":"21","author":"Verkman A.S.","year":"2017","unstructured":"Verkman A.S.; Smith A.J.; Phuan P.; Tradtrantip L.; Anderson M.O.; The aquaporin-4 water channel as a potential drug target in neurological disorders. Expert Opin Ther Targets 2017,21(12),1161-1170","journal-title":"Expert Opin Ther Targets"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1096\/fj.11-201608","volume":"26","author":"Tradtrantip L.","year":"2012","unstructured":"Tradtrantip L.; Zhang H.; Anderson M.O.; Saadoun S.; Phuan P.W.; Papadopoulos M.C.; Bennett J.L.; Verkman A.S.; Small-molecule inhibitors of NMO-IgG binding to aquaporin-4 reduce astrocyte cytotoxicity in neuromyelitis optica. FASEB J 2012,26(5),2197-2208","journal-title":"FASEB J"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"13829","DOI":"10.1074\/jbc.M112.344325","volume":"287","author":"Phuan P.W.","year":"2012","unstructured":"Phuan P.W.; Ratelade J.; Rossi A.; Tradtrantip L.; Verkman A.S.; Complement-dependent cytotoxicity in neuromyelitis optica requires aquaporin-4 protein assembly in orthogonal arrays. J Biol Chem 2012,287(17),13829-13839","journal-title":"J Biol Chem"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000444530","volume":"23","author":"Sun M.","year":"2016","unstructured":"Sun M.; Wang J.; Zhou Y.; Wang Z.; Jiang Y.; Li M.; Isotetrandrine reduces astrocyte cytotoxicity in neuromyelitis optica by blocking the binding of NMO-IgG to aquaporin 4. Neuroimmunomodulation 2016,23(2),98-108","journal-title":"Neuroimmunomodulation"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/ana.21802","volume":"66","author":"Bennett J.L.","year":"2009","unstructured":"Bennett J.L.; Lam C.; Kalluri S.R.; Saikali P.; Bautista K.; Dupree C.; Glogowska M.; Case D.; Antel J.P.; Owens G.P.; Gilden D.; Nessler S.; Stadelmann C.; Hemmer B.; Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol 2009,66(5),617-629","journal-title":"Ann Neurol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.4049\/jimmunol.171.5.2725","volume":"171","author":"Owens G.P.","year":"2003","unstructured":"Owens G.P.; Ritchie A.M.; Burgoon M.P.; Williamson R.A.; Corboy J.R.; Gilden D.H.; Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid. J Immunol 2003,171(5),2725-2733","journal-title":"J Immunol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1681\/ASN.2012030295","volume":"24","author":"Bogum J.","year":"2013","unstructured":"Bogum J.; Faust D.; Z\u00fchlke K.; Eichhorst J.; Moutty M.C.; Furkert J.; Eldahshan A.; Neuenschwander M.; von Kries J.P.; Wiesner B.; Trimpert C.; Deen P.M.T.; Valenti G.; Rosenthal W.; Klussmann E.; Small-molecule screening identifies modulators of aquaporin-2 trafficking. J Am Soc Nephrol 2013,24(5),744-758","journal-title":"J Am Soc Nephrol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"36837","DOI":"10.1074\/jbc.M112.408716","volume":"287","author":"a) Phuan P.W.","year":"2012","unstructured":"a) Phuan P.W.; Anderson M.O.; Tradtrantip L.; Zhang H.; Tan J.; Lam C.; Bennett J.L.; Verkman A.S.; A small- molecule screen yields idiotype-specific blockers of neuromyelitis optica immunoglobulin G binding to aquaporin-4. J Biol Chem 2012,287(44),36837-36844","journal-title":"J Biol Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"16516","DOI":"10.1074\/jbc.M111.227298","volume":"286","author":"Crane J.M.","year":"2011","unstructured":"Crane J.M.; Lam C.; Rossi A.; Gupta T.; Bennett J.L.; Verkman A.S.; Binding affinity and specificity of neuromyelitis optica autoantibodies to aquaporin-4 M1\/M23 isoforms and orthogonal arrays. J Biol Chem 2011,286(18),16516-16524","journal-title":"J Biol Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"C426","DOI":"10.1152\/ajpcell.00298.2003","volume":"286","author":"Solenov E.","year":"2004","unstructured":"Solenov E.; Watanabe H.; Manley G.T.; Verkman A.S.; Sevenfold-reduced osmotic water permeability in primary astrocyte cultures from AQP-4-deficient mice, measured by a fluorescence quenching method. Am J Physiol Cell Physiol 2004,286(2),C426-C432","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1523\/JNEUROSCI.17-03-00932.1997","volume":"17","author":"Swanson R.A.","year":"1997","unstructured":"Swanson R.A.; Liu J.; Miller J.W.; Rothstein J.D.; Farrell K.; Stein B.A.; Longuemare M.C.; Neuronal regulation of glutamate transporter subtype expression in astrocytes. J Neurosci 1997,17(3),932-940","journal-title":"J Neurosci"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.bcp.2017.12.023","volume":"151","author":"Li S.","year":"2018","unstructured":"Li S.; Uno Y.; Rudolph U.; Cobb J.; Liu J.; Anderson T.; Levy D.; Balu D.T.; Coyle J.T.; Astrocytes in primary cultures express serine racemase, synthesize d-serine and acquire A1 reactive astrocyte features. Biochem Pharmacol 2018,151,245-251","journal-title":"Biochem Pharmacol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/aps.2011.27","volume":"32","author":"Verkman A.S.","year":"2011","unstructured":"Verkman A.S.; Ratelade J.; Rossi A.; Zhang H.; Tradtrantip L.; Aquaporin-4: Orthogonal array assembly, CNS functions, and role in neuromyelitis optica. Acta Pharmacol Sin 2011,32(6),702-710","journal-title":"Acta Pharmacol Sin"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.3892\/mmr.2020.11212","volume":"22","author":"Wang J.","year":"2020","unstructured":"Wang J.; Wang S.; Sun M.; Xu H.; Liu W.; Wang D.; Zhang L.; Li Y.; Cao J.; Li F.; Li M.; Identification of geraldol as an inhibitor of aquaporin-4 binding by NMO-IgG. Mol Med Rep 2020,22(2),1111-1118","journal-title":"Mol Med Rep"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3389\/fncel.2017.00412","volume":"11","author":"Bi C.","year":"2017","unstructured":"Bi C.; Tham D.K.L.; Perronnet C.; Joshi B.; Nabi I.R.; Moukhles H.; The oxidative stress-induced increase in the membrane expression of the water-permeable channel aquaporin-4 in astrocytes is regulated by caveolin-1 phosphorylation. Front Cell Neurosci 2017,11,412","journal-title":"Front Cell Neurosci"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3892\/ijmm.2014.1791","volume":"34","author":"Willermain F.","year":"2014","unstructured":"Willermain F.; Janssens S.; Arsenijevic T.; Piens I.; Bolaky N.; Caspers L.; Perret J.; Delporte C.; Osmotic stress decreases aquaporin-4 expression in the human retinal pigment epithelial cell line, ARPE-19. Int J Mol Med 2014,34(2),533-538","journal-title":"Int J Mol Med"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12974-014-0184-5","volume":"11","author":"Chu H.","year":"2014","unstructured":"Chu H.; Xiang J.; Wu P.; Su J.; Ding H.; Tang Y.; Dong Q.; The role of aquaporin 4 in apoptosis after intracerebral hemorrhage. J Neuroinflammation 2014,11(1),184","journal-title":"J Neuroinflammation"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"e66751","DOI":"10.1371\/journal.pone.0066751","volume":"8","author":"Ding T.","year":"2013","unstructured":"Ding T.; Zhou Y.; Sun K.; Jiang W.; Li W.; Liu X.; Tian C.; Li Z.; Ying G.; Fu L.; Gu F.; Li W.; Ma Y.; Knockdown a water channel protein, aquaporin-4, induced glioblastoma cell apoptosis. PLoS One 2013,8(8),e66751","journal-title":"PLoS One"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jaut.2012.07.008","volume":"40","author":"Iorio R.","year":"2013","unstructured":"Iorio R.; Fryer J.P.; Hinson S.R.; Fallier-Becker P.; Wolburg H.; Pittock S.J.; Lennon V.A.; Astrocytic autoantibody of neuromyelitis optica (NMO-IgG) binds to aquaporin-4 extracellular loops, monomers, tetramers and high order arrays. J Autoimmun 2013,40,21-27","journal-title":"J Autoimmun"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"12123","DOI":"10.1074\/jbc.M115.647149","volume":"290","author":"Owens G.P.","year":"2015","unstructured":"Owens G.P.; Ritchie A.; Rossi A.; Schaller K.; Wemlinger S.; Schumann H.; Shearer A.; Verkman A.S.; Bennett J.L.; Mutagenesis of the aquaporin 4 extracellular domains defines restricted binding patterns of pathogenic neuromyelitis optica IgG. J Biol Chem 2015,290(19),12123-12134","journal-title":"J Biol Chem"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.bios.2015.11.029","volume":"78","author":"Son M.","year":"2016","unstructured":"Son M.; Kim D.; Park K.S.; Hong S.; Park T.H.; Detection of aquaporin-4 antibody using aquaporin-4 extracellular loop-based carbon nanotube biosensor for the diagnosis of neuromyelitis optica. Biosens Bioelectron 2016,78,87-91","journal-title":"Biosens Bioelectron"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12974-016-0642-3","volume":"13","author":"Tuller F.","year":"2016","unstructured":"Tuller F.; Holzer H.; Schanda K.; Aboulenein-Djamshidian F.; H\u00f6ftberger R.; Khalil M.; Seifert-Held T.; Leutmezer F.; Berger T.; Reindl M.; Characterization of the binding pattern of human aquaporin-4 autoantibodies in patients with neuromyelitis optica spectrum disorders. J Neuroinflammation 2016,13(1),176","journal-title":"J Neuroinflammation"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1212\/01.WNL.0000289761.64862.ce","volume":"69","author":"Hinson S.R.","year":"2007","unstructured":"Hinson S.R.; Pittock S.J.; Lucchinetti C.F.; Roemer S.F.; Fryer J.P.; Kryzer T.J.; Lennon V.A.; Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology 2007,69(24),2221-2231","journal-title":"Neurology"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1093\/brain\/awq177","volume":"133","author":"Marignier R.","year":"2010","unstructured":"Marignier R.; Nicolle A.; Watrin C.; Touret M.; Cavagna S.; Varrin-Doyer M.; Cavillon G.; Rogemond V.; Confavreux C.; Honnorat J.; Giraudon P.; Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury. Brain 2010,133(9),2578-2591","journal-title":"Brain"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1177\/1352458510382324","volume":"16","author":"Parratt J.D.E.","year":"2010","unstructured":"Parratt J.D.E.; Prineas J.W.; Neuromyelitis optica: A demyelinating disease characterized by acute destruction and regeneration of perivascular astrocytes. Mult Scler 2010,16(10),1156-1172","journal-title":"Mult Scler"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1135\/cccc19620255","volume":"27","author":"Hrbek J.","year":"1962","unstructured":"Hrbek J.; \u0160antav\u00fd F.; Substanzen der Pflanzen der Unterfamilie Wurmbaeoideae und ihre Derivate LI. Isolierung der Alkaloide vom Colchicintypus aus einigen afrikanischen Arten der Unterfamilie Wurmbaeoideae. Collect Czech Chem Commun 1962,27(1),255-267","journal-title":"Collect Czech Chem Commun"}],"container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1381612829666230330090953","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/215176\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1381612829666230330090953","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T05:59:32Z","timestamp":1692251972000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/215176\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":46,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1381612829666230330090953","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-07-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}